Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Cash from Investing Activities (2022 - 2025)

Entrada Therapeutics has reported Cash from Investing Activities over the past 4 years, most recently at $29.1 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at $29.1 million for Q4 2025, down 45.43% from a year ago — trailing twelve months through Dec 2025 was $116.8 million (up 520.2% YoY), and the annual figure for FY2025 was $116.8 million, up 520.2%.
  • Cash from Investing Activities for Q4 2025 was $29.1 million at Entrada Therapeutics, down from $49.1 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for TRDA hit a ceiling of $53.4 million in Q4 2024 and a floor of -$181.5 million in Q1 2022.
  • Median Cash from Investing Activities over the past 4 years was $11.8 million (2022), compared with a mean of -$12.4 million.
  • Biggest five-year swings in Cash from Investing Activities: crashed 2119.08% in 2024 and later surged 238.61% in 2025.
  • Entrada Therapeutics' Cash from Investing Activities stood at $18.8 million in 2022, then grew by 1.34% to $19.0 million in 2023, then soared by 180.23% to $53.4 million in 2024, then tumbled by 45.43% to $29.1 million in 2025.
  • The last three reported values for Cash from Investing Activities were $29.1 million (Q4 2025), $49.1 million (Q3 2025), and $33.8 million (Q2 2025) per Business Quant data.